Ancient Chinese Preventive Medicine Meets AI in Proposed Digital Health Framework

A team of researchers from Quzhou Hospital of Traditional Chinese Medicine and Quzhou College of Technology has proposed a testable conceptual framework that fuses the ancient Traditional Chinese Medicine (TCM) principle of “Preventing a Disease Before It Arises” with modern digital intelligence. Writing in Frontiers in Digital Health, the authors, led by Hui Xu and Binyu Luo, are careful to frame their work as a research agenda rather than a clinically validated system. The proposal organizes existing component-level evidence into an explicit architecture designed for future evaluation of feasibility, effectiveness, safety, equity, implementation, and cost-effectiveness.

The motivation behind the framework is stark. Non-communicable diseases now account for approximately 71 percent of all deaths worldwide each year, according to World Health Organization reports cited in the paper. The traditional “reactive” medical model, in which patients seek treatment only after falling ill, is increasingly strained by chronic diseases appearing in younger populations and by aging societies. The authors argue this has forced a transition from “disease treatment” toward “health medicine,” a prevention-first paradigm that aligns closely with the TCM concept of Zhi Wei Bing, a doctrine rooted in the Huangdi Neijing, the Yellow Emperor’s Inner Canon, which holds that the skilled physician treats disease before it arises.

The TCM doctrine encompasses three progressive levels. “Pre-disease prevention” targets sub-healthy individuals who carry risks for chronic conditions but do not yet meet clinical diagnostic criteria. “Preventing disease progression” focuses on early recognition of clinical change and timely intervention for patients already diagnosed with chronic diseases in their early stages. “Preventing recurrence” addresses people in recovery. The authors note that their operational framework focuses on the first two groups, while recurrence prevention and rehabilitation remain part of the broader theoretical continuum but are not fully operationalized as target populations.

The central problem the researchers identify is what they call a spatio-temporal limitation and data gap. Traditional TCM preventive services depend heavily on the personal experience of practitioners and the subjective perception of patients, rely on point-in-time examinations, and are largely confined to medical institutions. This makes continuous, precise risk early-warning difficult and constrains access at the grassroots level. Digital technologies, including the Internet of Things and artificial intelligence, could enable repeated or continuous monitoring, risk assessment, and digitally supported intervention, though the authors emphasize that effectiveness and generalizability vary across applications and settings.

The proposed architecture makes several conceptual shifts. The first moves from point-in-time assessment to longitudinal digital phenotyping, in which wearables, smartphone sensors, and multimodal data fusion continuously and passively capture behavioral, physiological, psychological, and environmental data. Research on deep phenotyping, such as a 2025 study in Nature Medicine combining continuous glucose monitoring, sleep tracking, and multi-omics data, illustrates how such methods can characterize changes along the health-disease continuum. In the proposed framework, digital phenotyping could support earlier identification and risk stratification, but its incremental predictive and clinical value remains subject to prospective validation.

The second shift moves from population-level management to precision, constitution-based health cultivation. TCM constitution theory, developed by Academician Wang Qi’s team, provides the theoretical basis for individualized intervention, but traditional constitution identification depends on practitioner experience, making it hard to scale. Machine learning is changing this: the TCM-DS large language model developed by Li and colleagues automatically generates personalized medicinal and edible homology formulas from symptom and constitution data and reported a recommendation precision of 0.9924 for the specific task and dataset evaluated. The authors stress this is task-level technical performance, not established clinical effectiveness, and that prospective external validation is required before application to high-risk populations.

The third shift replaces experience-driven practice with a dual-engine fusion architecture. At each time point, multimodal observations are split into biomedical measurements, TCM-specific perceptual and symptom data such as tongue, facial, vocal, and gait features, and behavioral or environmental information. A biomedical risk engine generates estimates of disease-onset or progression risk with associated uncertainty, while a TCM reasoning engine produces probability-weighted constitution and syndrome profiles informed by a curated knowledge base. Knowledge-graph and large-language-model approaches, including the TCM-KLLaMA model, which reported fewer hallucination-related errors in formula generation after knowledge injection, illustrate how expert knowledge could be structured and retrieved to support this reasoning component.

Crucially, the framework separates prognostic risk from intervention selection. A predicted risk estimate answers who is at higher risk; it does not establish who will benefit from a particular treatment. Candidate interventions must therefore be linked to validated intervention-effect evidence, applicable clinical guidelines, safety constraints, and clinical context, and clinically consequential options require clinician review with explicit mechanisms for confirmation, modification, override, or escalation. In the absence of validated evidence, elevated risk may justify intensified monitoring, reassessment, or referral, but not a specific treatment recommendation. The authors also cite a 12-month controlled study by Qin and colleagues, which found that TCM artificial intelligence health management for people at high risk of and patients with type 2 diabetes was associated with significantly greater reductions in blood pressure, blood glucose, and blood lipids compared to usual care, though this is component-level evidence rather than proof of the integrated architecture.

The authors are candid about the obstacles. Data silos, in which medical information systems, wearable devices, and personal health records belong to different management entities, restrict large-scale health-data utilization, and privacy risks are heightened because TCM data includes characteristic information such as tongue signs, pulse signs, and constitution types. Algorithmic bias may arise from single-center sampling, regional differences, device variability, and variability among TCM labelers. Primary healthcare staff often lack digital literacy and may experience technology anxiety, while elderly patients face a digital divide in operating intelligent equipment. Standardization of TCM perceptual data also lags, with inconsistent lighting conditions and sensor specifications across manufacturers affecting image reproducibility. No evidence currently establishes the cost-effectiveness of the complete architecture.

The proposed path forward is staged. Validation would begin with data quality, measurement agreement, discrimination, calibration, and external validity across sites and devices, then proceed to feasibility pilots assessing recruitment, adherence, and workflow burden, and finally to multicenter pragmatic or cluster-randomized studies evaluating clinical, safety, equity, and economic outcomes. Privacy-preserving approaches such as federated learning, regional data-sharing platforms, lightweight intelligent equipment, and international standards for TCM tongue-image data exchange, which the World Federation of Chinese Medicine Societies has initiated, could support this pathway. The authors conclude that digitalized preventive treatment may contribute to more continuous and proactive chronic-disease management, but only if rigorous evaluation demonstrates its value before large-scale deployment.

Subject of Research: A proposed conceptual framework integrating TCM preventive treatment with digital health technology for chronic disease management

Article Title: Digitalized “preventive treatment” in chronic disease control and proactive health: a perspective on integrating TCM wisdom with digital intelligence

Article References: Xu, H., Luo, B., Hu, F., Gu, J., Shen, G., Xu, J., Fang, F., & Qiu, H. (2026). Digitalized “preventive treatment” in chronic disease control and proactive health: a perspective on integrating TCM wisdom with digital intelligence. Frontiers in Digital Health, 8, Article 1883420. https://doi.org/10.3389/fdgth.2026.1883420

Image Credits: AI Generated

DOI: 10.3389/fdgth.2026.1883420

Keywords: Traditional Chinese Medicine, digital health, artificial intelligence, chronic disease prevention, preventive treatment, digital phenotyping, machine learning, large language models, health data governance, prediabetes, risk prediction, Zhi Wei Bing